AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Liyan Zhang(Zhongda Hospital Southeast University), Renjie Chai(Medical Protective), Yinyi Zhou(Zhongda Hospital Southeast University), Fangzhi Tan(Zhongda Hospital Southeast University), Nianci Li(Zhongda Hospital Southeast University), Xinru Zhang(Zhongda Hospital Southeast University), Shiming Yang(Ministry of Education of the People's Republic of China), Xiaohan Wang(Zhongda Hospital Southeast University), Lei Xu(Shandong University), Xiangyan Chen(Chengdu Medical College), Peng Li, Jinyi Fan(Zhongda Hospital Southeast University), Jieyu Qi(Medical Protective), Yicheng Lu(Nantong University), Xuehan Yang(Zhongda Hospital Southeast University)
Cited by 33
Related Papers
Mutations in <i>TUBB8</i> and Human Oocyte Meiotic Arrest
|New England Journal of Medicine|2016|324
AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial
|The Lancet|2024|323
AAV-ie enables safe and efficient gene transfer to inner ear cells
|Nature Communications|2019|228
Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition
|Nature Cell Biology|2024|198
AAV‐Mediated Gene Therapy Restores Hearing in Patients with DFNB9 Deafness
|Advanced Science|2024|176